Tag: abeona therapeutics
April 30, 2019
Abeona Therapeutics Presents New Preclinical Data of ABO-401
Abeona Therapeutics announced the presentation of new preclinical data on its candidate ABO-401. December 7, 2018
Abeona Therapeutics Details Pathway for Advancing Lead Clinical Programs
Abeona Therapeutics (Nasdaq:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic... April 23, 2018
Abeona Announces FDA Grants RMAT Designation to ABO-102 Gene Therapy in MPS IIIA
Abeona Therapeutics (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic... April 20, 2018
Abeona Therapeutics Receives Orphan Drug Designation in the European Union for ABO-202 Gene Therapy Program in Batten Disease
Abeona Therapeutics (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic... March 15, 2018
Abeona Therapeutics Receives FDA Rare Pediatric Disease Designation for ABO-202 Gene Therapy Program in CLN1 Disease
Abeona Therapeutics (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic...
February 15, 2018
Agios Receives FDA Priority Review for New Drug Application: How are Gene Therapy Drug Approvals Impacting Stocks?
INN is taking a look at what other companies have received FDA approval for gene therapy drugs and how the... February 13, 2018